Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

NCT01658826 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
91
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AiCuris Anti-infective Cures AG

Collaborators